Serum DFMO concentration versus time measurements for three patients receiving 750 mg/m2 PO BID during cycle 1 of therapy.

Predicted TFV-DP intracellular pharmacokinetics following a single dose oral 300 mg TDF and accumulation of TFV-DP after daily 300 mg oral TDF.

Sulav Duwal (152805)
Christof Schütte (151327)
Max von Kleist (152808)

July 2012

A: Predicted intracellular pharmacokinetics of TFV-DP in PBMCs after a single 300 mg oral TDF dos...

Serum Mb concentrations determined at all times points for the three conditions.

Fernando Naclerio (730648)
Eneko Larumbe-Zabala (730649)
Robert Cooper (730650)
Judith Allgrove (730651)
Conrad P. Earnest (163395)

April 2015

*p<0.05 compared to pre for the three conditions; ξ p<0.01 from 1h to immediately after (post) on...

The plasma concentration-time profiles of digoxin and ginsenoside Rb1, Rb2, Rc and Rd after multi-dose of vehicle / SLE and GE.

Yan Liang (139654)
Yuanyuan Zhou (389970)
Jingwei Zhang (288128)
Tai Rao (577468)
Lijun Zhou (577469)
Rong Xing (577470)
Qian Wang (32718)
Hanxu Fu (577471)
Kun Hao (276965)
Lin Xie (136792)
Guangji Wang (141875)

June 2014

The plasma concentration-time profiles of digoxin and ginsenoside Rb1, Rb2, Rc and Rd after multi...

Serum TFV and TFV-DP concentration versus time.

Craig W. Hendrix (232212)
Beatrice A. Chen (278025)
Vijayanand Guddera (278026)
Craig Hoesley (278027)
Jessica Justman (278028)
Clemensia Nakabiito (224531)
Robert Salata (278029)
Lydia Soto-Torres (232208)
Karen Patterson (278030)
Alexandra M. Minnis (278032)
Sharavi Gandham (278034)
Kailazarid Gomez (278035)
Barbra A. Richardson (172638)
Namandje N. Bumpus (278036)

January 2013

Serum TFV (panel A) and PBMC TFV-DP (panel B) concentration versus time plots are shown for the o...

Urinary polyamine metabolites from patients at baseline and during first two weeks of DFMO therapy.

Giselle L. Saulnier Sholler (745739)
Eugene W. Gerner (745740)
Genevieve Bergendahl (745741)
Robert B. MacArthur (745742)
Alyssa VanderWerff (745743)
Takamaru Ashikaga (745744)
Jeffrey P. Bond (108228)
William Ferguson (745745)
William Roberts (497062)
Randal K. Wada (745746)
Don Eslin (745747)
Jacqueline M. Kraveka (745748)
Joel Kaplan (745749)
Deanna Mitchell (745750)
Nehal S. Parikh (745751)
Kathleen Neville (745752)
Leonard Sender (745753)
Timothy Higgins (745754)
Masao Kawakita (745755)
Kyoko Hiramatsu (745756)
Shun-suke Moriya (745757)
André S. Bachmann (745758)

May 2015

C1D1 = cycle 1 day 1 (defined as baseline)C1D8 = cycle 1 day 8 after starting DFMO on day1...

Clinical chemistry and hematology results after 7-day continuous PO dosing via medicated gels versus the water control group(average±SD).

Liselot M. Mus (4875943)
Geertrui Denecker (439825)
Frank Speleman (800)
Bart I. Roman (2413753)

February 2018

Clinical chemistry and hematology results after 7-day continuous PO dosing via medicated gels ver...

Mean plasma concentration-time curves of gemcitabine (A) and dFdU (B) (mean ± standard deviation).

Yutaka Fujiwara (615517)
Shogo Kobayashi (833260)
Hiroaki Nagano (282467)
Masashi Kanai (833261)
Etsuo Hatano (833262)
Masanori Toyoda (615518)
Tetsuo Ajiki (833263)
Yuki Takashima (833264)
Kenichi Yoshimura (637501)
Akinobu Hamada (833265)
Hironobu Minami (411771)
Tatsuya Ioka (128630)

December 2015

Mean plasma concentration-time curves of gemcitabine (A) and dFdU (B) (mean ± standard deviation)...

Mean concentration of DMAMCL in plasma and brain at different time after administration.

Yinghong An (690209)
Wanjun Guo (690210)
Linna Li (690211)
Chengwang Xu (690212)
Dexuan Yang (690213)
Shanshan Wang (283009)
Yaxin Lu (690214)
Quan Zhang (168081)
Jiadai Zhai (690215)
Hongxia Fan (420601)
Chuanjiang Qiu (690216)
Jie Qi (53195)
Yue Chen (73753)
Shoujun Yuan (690217)

February 2015

Mean concentration of DMAMCL in plasma and brain at different time after administration.</p

Simplified Equations Using Two Concentrations To Calculate Area under the Curve for Antimicrobials with Concentration-Dependent Pharmacodynamics: Daptomycin as a Motivating Example

M.p. Pai
A. Russo
A. Novelli
Mario Venditti
Marco Falcone

January 2014

The effects of several antimicrobial agents are predicted by the ratio of the area under the concent...

Blood glucose concentrations at 45 min post 2-deoxyglucose administration.

Akansha Mishra (2632600)
Simone Hernandez Ruano (12289960)
Pradip K. Saha (14265606)
Kathleen A. Pennington (3170085)

December 2022

Blood glucose concentrations were not different among groups 45 minutes post 2-deoxyglucose administ...

HFO reduction in the presence of DMSO.

Yuan-Yuan Cheng (481023)
Bing-Bing Li (481024)
Dao-Bo Li (481025)
Jie-Jie Chen (481026)
Wen-Wei Li (481027)
Zhong-Hua Tong (481028)
Chao Wu (199897)
Han-Qing Yu (481029)

November 2013

(A) HFO reduction by S. oneidensis MR-1 with different concentration of DMSO. (B) Fe(II) p...

Mean plasma concentration versus time plots for SRT2104 on day 1 and 28, following multiple dose administration of 0.5 g/day (top panel) and 2.0 g/day (lower panel) to elderly male and female volunteers.

Vincenzo Libri (48937)
Andrew P. Brown (108833)
Giulio Gambarota (108837)
Jonathan Haddad (108841)
Gregory S. Shields (108844)
Helen Dawes (108846)
David J. Pinato (108849)
Ethan Hoffman (108852)
Peter J. Elliot (108855)
George P. Vlasuk (108857)
Eric Jacobson (108858)
Martin R. Wilkins (108859)
Paul M. Matthews (108861)

December 2012

Mean plasma concentration versus time plots for SRT2104 on day 1 and 28, following multiple dose ...

The rate of prothrombin time measurements during the warfarin therapy in patients with incident NVAF *.

Kiyoshi Kubota (561420)
Nobuhiro Ooba (561411)
Yukari Kamijima (5721233)
Kuniyasu Sato (5721236)
Daisuke Koide (652787)

September 2018

The rate of prothrombin time measurements during the warfarin therapy in patients with incident NVAF...

Variation of serum S1P levels throughout the course of the illness in patients with DF and DHF.

Laksiri Gomes (296923)
Samitha Fernando (663503)
Randika Heshan Fernando (663504)
Nilanka Wickramasinghe (663505)
Narangoda Liyanage Ajantha Shyamali (663506)
Graham S. Ogg (247757)
Gathsaurie Neelika Malavige (296920)

November 2014

A: S1P levels in patients with DHF (n = 22). The bars indicate the mean and the standard error of...

Ratio of unphosphorylated TFV to phosphorylated TFV-DP by anatomic sampling sites.

Craig W. Hendrix (232212)
Beatrice A. Chen (278025)
Vijayanand Guddera (278026)
Craig Hoesley (278027)
Jessica Justman (278028)
Clemensia Nakabiito (224531)
Robert Salata (278029)
Lydia Soto-Torres (232208)
Karen Patterson (278030)
Alexandra M. Minnis (278032)
Sharavi Gandham (278034)
Kailazarid Gomez (278035)
Barbra A. Richardson (172638)
Namandje N. Bumpus (278036)

January 2013

Pairs are included if at least one value in the pair is above the limit of assay quantitation and...

Predicted TFV-DP intracellular pharmacokinetics following a single dose oral 300 mg TDF and accumulation of TFV-DP after daily 300 mg oral TDF.

Sulav Duwal (152805)
Christof Schütte (151327)
Max von Kleist (152808)

July 2012

A: Predicted intracellular pharmacokinetics of TFV-DP in PBMCs after a single 300 mg oral TDF dos...

Serum Mb concentrations determined at all times points for the three conditions.

Fernando Naclerio (730648)
Eneko Larumbe-Zabala (730649)
Robert Cooper (730650)
Judith Allgrove (730651)
Conrad P. Earnest (163395)

April 2015

*p<0.05 compared to pre for the three conditions; ξ p<0.01 from 1h to immediately after (post) on...

The plasma concentration-time profiles of digoxin and ginsenoside Rb1, Rb2, Rc and Rd after multi-dose of vehicle / SLE and GE.

Yan Liang (139654)
Yuanyuan Zhou (389970)
Jingwei Zhang (288128)
Tai Rao (577468)
Lijun Zhou (577469)
Rong Xing (577470)
Qian Wang (32718)
Hanxu Fu (577471)
Kun Hao (276965)
Lin Xie (136792)
Guangji Wang (141875)

June 2014

The plasma concentration-time profiles of digoxin and ginsenoside Rb1, Rb2, Rc and Rd after multi...

Serum TFV and TFV-DP concentration versus time.

Craig W. Hendrix (232212)
Beatrice A. Chen (278025)
Vijayanand Guddera (278026)
Craig Hoesley (278027)
Jessica Justman (278028)
Clemensia Nakabiito (224531)
Robert Salata (278029)
Lydia Soto-Torres (232208)
Karen Patterson (278030)
Alexandra M. Minnis (278032)
Sharavi Gandham (278034)
Kailazarid Gomez (278035)
Barbra A. Richardson (172638)
Namandje N. Bumpus (278036)

January 2013

Serum TFV (panel A) and PBMC TFV-DP (panel B) concentration versus time plots are shown for the o...

Urinary polyamine metabolites from patients at baseline and during first two weeks of DFMO therapy.

Giselle L. Saulnier Sholler (745739)
Eugene W. Gerner (745740)
Genevieve Bergendahl (745741)
Robert B. MacArthur (745742)
Alyssa VanderWerff (745743)
Takamaru Ashikaga (745744)
Jeffrey P. Bond (108228)
William Ferguson (745745)
William Roberts (497062)
Randal K. Wada (745746)
Don Eslin (745747)
Jacqueline M. Kraveka (745748)
Joel Kaplan (745749)
Deanna Mitchell (745750)
Nehal S. Parikh (745751)
Kathleen Neville (745752)
Leonard Sender (745753)
Timothy Higgins (745754)
Masao Kawakita (745755)
Kyoko Hiramatsu (745756)
Shun-suke Moriya (745757)
André S. Bachmann (745758)

May 2015

C1D1 = cycle 1 day 1 (defined as baseline)C1D8 = cycle 1 day 8 after starting DFMO on day1...

Clinical chemistry and hematology results after 7-day continuous PO dosing via medicated gels versus the water control group(average±SD).

Liselot M. Mus (4875943)
Geertrui Denecker (439825)
Frank Speleman (800)
Bart I. Roman (2413753)

February 2018

Clinical chemistry and hematology results after 7-day continuous PO dosing via medicated gels ver...

Mean plasma concentration-time curves of gemcitabine (A) and dFdU (B) (mean ± standard deviation).

Yutaka Fujiwara (615517)
Shogo Kobayashi (833260)
Hiroaki Nagano (282467)
Masashi Kanai (833261)
Etsuo Hatano (833262)
Masanori Toyoda (615518)
Tetsuo Ajiki (833263)
Yuki Takashima (833264)
Kenichi Yoshimura (637501)
Akinobu Hamada (833265)
Hironobu Minami (411771)
Tatsuya Ioka (128630)

December 2015

Mean plasma concentration-time curves of gemcitabine (A) and dFdU (B) (mean ± standard deviation)...

Mean concentration of DMAMCL in plasma and brain at different time after administration.

Yinghong An (690209)
Wanjun Guo (690210)
Linna Li (690211)
Chengwang Xu (690212)
Dexuan Yang (690213)
Shanshan Wang (283009)
Yaxin Lu (690214)
Quan Zhang (168081)
Jiadai Zhai (690215)
Hongxia Fan (420601)
Chuanjiang Qiu (690216)
Jie Qi (53195)
Yue Chen (73753)
Shoujun Yuan (690217)

February 2015

Mean concentration of DMAMCL in plasma and brain at different time after administration.</p

Simplified Equations Using Two Concentrations To Calculate Area under the Curve for Antimicrobials with Concentration-Dependent Pharmacodynamics: Daptomycin as a Motivating Example

M.p. Pai
A. Russo
A. Novelli
Mario Venditti
Marco Falcone

January 2014

The effects of several antimicrobial agents are predicted by the ratio of the area under the concent...

Blood glucose concentrations at 45 min post 2-deoxyglucose administration.

Akansha Mishra (2632600)
Simone Hernandez Ruano (12289960)
Pradip K. Saha (14265606)
Kathleen A. Pennington (3170085)

December 2022

Blood glucose concentrations were not different among groups 45 minutes post 2-deoxyglucose administ...

HFO reduction in the presence of DMSO.

Yuan-Yuan Cheng (481023)
Bing-Bing Li (481024)
Dao-Bo Li (481025)
Jie-Jie Chen (481026)
Wen-Wei Li (481027)
Zhong-Hua Tong (481028)
Chao Wu (199897)
Han-Qing Yu (481029)

November 2013

(A) HFO reduction by S. oneidensis MR-1 with different concentration of DMSO. (B) Fe(II) p...

Mean plasma concentration versus time plots for SRT2104 on day 1 and 28, following multiple dose administration of 0.5 g/day (top panel) and 2.0 g/day (lower panel) to elderly male and female volunteers.

Vincenzo Libri (48937)
Andrew P. Brown (108833)
Giulio Gambarota (108837)
Jonathan Haddad (108841)
Gregory S. Shields (108844)
Helen Dawes (108846)
David J. Pinato (108849)
Ethan Hoffman (108852)
Peter J. Elliot (108855)
George P. Vlasuk (108857)
Eric Jacobson (108858)
Martin R. Wilkins (108859)
Paul M. Matthews (108861)

December 2012

Mean plasma concentration versus time plots for SRT2104 on day 1 and 28, following multiple dose ...

The rate of prothrombin time measurements during the warfarin therapy in patients with incident NVAF *.

Kiyoshi Kubota (561420)
Nobuhiro Ooba (561411)
Yukari Kamijima (5721233)
Kuniyasu Sato (5721236)
Daisuke Koide (652787)

September 2018

The rate of prothrombin time measurements during the warfarin therapy in patients with incident NVAF...

Variation of serum S1P levels throughout the course of the illness in patients with DF and DHF.

Laksiri Gomes (296923)
Samitha Fernando (663503)
Randika Heshan Fernando (663504)
Nilanka Wickramasinghe (663505)
Narangoda Liyanage Ajantha Shyamali (663506)
Graham S. Ogg (247757)
Gathsaurie Neelika Malavige (296920)

November 2014

A: S1P levels in patients with DHF (n = 22). The bars indicate the mean and the standard error of...

Ratio of unphosphorylated TFV to phosphorylated TFV-DP by anatomic sampling sites.

Craig W. Hendrix (232212)
Beatrice A. Chen (278025)
Vijayanand Guddera (278026)
Craig Hoesley (278027)
Jessica Justman (278028)
Clemensia Nakabiito (224531)
Robert Salata (278029)
Lydia Soto-Torres (232208)
Karen Patterson (278030)
Alexandra M. Minnis (278032)
Sharavi Gandham (278034)
Kailazarid Gomez (278035)
Barbra A. Richardson (172638)
Namandje N. Bumpus (278036)

January 2013

Pairs are included if at least one value in the pair is above the limit of assay quantitation and...

Predicted TFV-DP intracellular pharmacokinetics following a single dose oral 300 mg TDF and accumulation of TFV-DP after daily 300 mg oral TDF.

Sulav Duwal (152805)
Christof Schütte (151327)
Max von Kleist (152808)

July 2012

A: Predicted intracellular pharmacokinetics of TFV-DP in PBMCs after a single 300 mg oral TDF dos...

Serum Mb concentrations determined at all times points for the three conditions.

Fernando Naclerio (730648)
Eneko Larumbe-Zabala (730649)
Robert Cooper (730650)
Judith Allgrove (730651)
Conrad P. Earnest (163395)

April 2015

*p<0.05 compared to pre for the three conditions; ξ p<0.01 from 1h to immediately after (post) on...

The plasma concentration-time profiles of digoxin and ginsenoside Rb1, Rb2, Rc and Rd after multi-dose of vehicle / SLE and GE.

Yan Liang (139654)
Yuanyuan Zhou (389970)
Jingwei Zhang (288128)
Tai Rao (577468)
Lijun Zhou (577469)
Rong Xing (577470)
Qian Wang (32718)
Hanxu Fu (577471)
Kun Hao (276965)
Lin Xie (136792)
Guangji Wang (141875)

June 2014

The plasma concentration-time profiles of digoxin and ginsenoside Rb1, Rb2, Rc and Rd after multi...

Serum DFMO concentration versus time measurements for three patients receiving 750 mg/m<sup>2</sup> PO BID during cycle 1 of therapy.

Abstract

Extracted data

Serum DFMO concentration versus time measurements for three patients receiving 750 mg/m<sup>2</sup> PO BID during cycle 1 of therapy.

Abstract

Extracted data

Related items

Related items